Mesengenic Differentiation: Comparison of Human and Rat Bone Marrow Mesenchymal Stem Cells

Overview

Journal Int J Stem Cells

Date 2014 Dec 5

PMID 25473450

Citations 14

Authors

Arianna Scuteri

Elisabetta Donzelli

Dana Foudah

Cristina Caldara

Juliana Redondo

Giovanna DAmico

Giovanni Tredici

Mariarosaria Miloso

Affiliations

Soon will be listed here.

Abstract

Background And Objectives: Cellular therapies using Mesenchymal Stem Cells (MSCs) represent a promising approach for the treatment of degenerative diseases, in particular for mesengenic tissue regeneration. However, before the approval of clinical trials in humans, in vitro studies must be performed aimed at investigating MSCs' biology and the mechanisms regulating their proliferation and differentiation abilities. Besides studies on human MSCs (hMSCs), MSCs derived from rodents have been the most used cellular type for in vitro studies. Nevertheless, the transfer of the results obtained using animal MSCs to hMSCs has been hindered by the limited knowledge regarding the similarities existing between cells of different origins. Aim of this paper is to highlight similarities and differences and to clarify the sometimes reported different results obtained using these cells.

Methods And Results: We compare the differentiation ability into mesengenic lineages of rat and human MSCs cultured in their standard conditions. Our results describe in which way the source from which MSCs are derived affects their differentiation potential, depending on the mesengenic lineage considered. For osteogenic and chondrogenic lineages, the main difference between human and rat MSCs is represented by differentiation time, while for adipogenesis hMSCs have a greater differentiation potential.

Conclusions: These results on the one hand suggest to carefully evaluate the transfer of results obtained with animal MSCs, on the other hand they offer a clue to better apply MSCs into clinical practice.

Citing Articles

Mesenchymal stem cells limit vascular and epithelial damage and restore the impermeability of the urothelium in chronic radiation cystitis.

Brossard C, Pouliet A, Lefranc A, Benadjaoud M, Dos Santos M, Demarquay C Stem Cell Res Ther. 2023; 14(1):5.

PMID: 36627674 PMC: 9832809. DOI: 10.1186/s13287-022-03230-2.

Antibacterial Titanium Implants Biofunctionalized by Plasma Electrolytic Oxidation with Silver, Zinc, and Copper: A Systematic Review.

van Hengel I, Tierolf M, Fratila-Apachitei L, Apachitei I, Zadpoor A Int J Mol Sci. 2021; 22(7).

PMID: 33917615 PMC: 8038786. DOI: 10.3390/ijms22073800.

Therapeutic Use of Mesenchymal Stromal Cells: The Need for Inclusive Characterization Guidelines to Accommodate All Tissue Sources and Species.

Wright A, Arthaud-Day M, Weiss M Front Cell Dev Biol. 2021; 9:632717.

PMID: 33665190 PMC: 7921162. DOI: 10.3389/fcell.2021.632717.

IL-1 Receptor Antagonist Protects the Osteogenesis Capability of Gingival-Derived Stem/Progenitor Cells under Inflammatory Microenvironment Induced by Lipopolysaccharides.

Zhao Y, Cai B, Zhu W, Shi J, Wang Y, Si M Stem Cells Int. 2021; 2021:6638575.

PMID: 33531908 PMC: 7834827. DOI: 10.1155/2021/6638575.

Immobilized DNA aptamers used as potent attractors for vascular endothelial cell: in vitro study of female rat.

Cha J, Lee H, Kim M, Kang J, Song H, Kim M Biosci Rep. 2020; 40(1).

PMID: 31930392 PMC: 6992924. DOI: 10.1042/BSR20182444.

References

Zhukareva V, Obrocka M, Houle J, Fischer I, Neuhuber B . Secretion profile of human bone marrow stromal cells: donor variability and response to inflammatory stimuli. Cytokine. 2010; 50(3):317-21. DOI: 10.1016/j.cyto.2010.01.004. View

Foudah D, Redaelli S, Donzelli E, Bentivegna A, Miloso M, Dalpra L . Monitoring the genomic stability of in vitro cultured rat bone-marrow-derived mesenchymal stem cells. Chromosome Res. 2009; 17(8):1025-39. PMC: 2793379. DOI: 10.1007/s10577-009-9090-6. View

Montzka K, Lassonczyk N, Tschoke B, Neuss S, Fuhrmann T, Franzen R . Neural differentiation potential of human bone marrow-derived mesenchymal stromal cells: misleading marker gene expression. BMC Neurosci. 2009; 10:16. PMC: 2655300. DOI: 10.1186/1471-2202-10-16. View

Ren G, Su J, Zhang L, Zhao X, Ling W, Lhuillie A . Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression. Stem Cells. 2009; 27(8):1954-62. DOI: 10.1002/stem.118. View

Redaelli S, Bentivegna A, Foudah D, Miloso M, Redondo J, Riva G . From cytogenomic to epigenomic profiles: monitoring the biologic behavior of in vitro cultured human bone marrow mesenchymal stem cells. Stem Cell Res Ther. 2012; 3(6):47. PMC: 3580477. DOI: 10.1186/scrt138. View

Donzelli E, Salvade A, Mimo P, Vigano M, Morrone M, Papagna R . Mesenchymal stem cells cultured on a collagen scaffold: In vitro osteogenic differentiation. Arch Oral Biol. 2006; 52(1):64-73. DOI: 10.1016/j.archoralbio.2006.07.007. View

Wieczorek G, Steinhoff C, Schulz R, Scheller M, Vingron M, Ropers H . Gene expression profile of mouse bone marrow stromal cells determined by cDNA microarray analysis. Cell Tissue Res. 2003; 311(2):227-37. DOI: 10.1007/s00441-002-0671-3. View

Orciani M, Di Primio R . Skin-derived mesenchymal stem cells: isolation, culture, and characterization. Methods Mol Biol. 2013; 989:275-83. DOI: 10.1007/978-1-62703-330-5_21. View

Foudah D, Redondo J, Caldara C, Carini F, Tredici G, Miloso M . Expression of neural markers by undifferentiated rat mesenchymal stem cells. J Biomed Biotechnol. 2012; 2012:820821. PMC: 3474592. DOI: 10.1155/2012/820821. View

10.

Coipeau P, Rosset P, Langonne A, Gaillard J, Delorme B, Rico A . Impaired differentiation potential of human trabecular bone mesenchymal stromal cells from elderly patients. Cytotherapy. 2009; 11(5):584-94. DOI: 10.1080/14653240903079385. View

11.

Chu C, Szczodry M, Bruno S . Animal models for cartilage regeneration and repair. Tissue Eng Part B Rev. 2009; 16(1):105-15. PMC: 3121784. DOI: 10.1089/ten.TEB.2009.0452. View

12.

Reilly G, Radin S, Chen A, Ducheyne P . Differential alkaline phosphatase responses of rat and human bone marrow derived mesenchymal stem cells to 45S5 bioactive glass. Biomaterials. 2007; 28(28):4091-7. PMC: 2699612. DOI: 10.1016/j.biomaterials.2007.05.038. View

13.

Foudah D, Redondo J, Caldara C, Carini F, Tredici G, Miloso M . Human mesenchymal stem cells express neuronal markers after osteogenic and adipogenic differentiation. Cell Mol Biol Lett. 2013; 18(2):163-86. PMC: 6275956. DOI: 10.2478/s11658-013-0083-2. View

14.

Prockop D . Marrow stromal cells as stem cells for nonhematopoietic tissues. Science. 1997; 276(5309):71-4. DOI: 10.1126/science.276.5309.71. View

15.

Lee K, Kuo T, Whang-Peng J, Chung Y, Lin C, Chou S . In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology. 2004; 40(6):1275-84. DOI: 10.1002/hep.20469. View

16.

Uccelli A, Moretta L, Pistoia V . Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2009; 8(9):726-36. DOI: 10.1038/nri2395. View

17.

Abdallah B, Kassem M . The use of mesenchymal (skeletal) stem cells for treatment of degenerative diseases: current status and future perspectives. J Cell Physiol. 2008; 218(1):9-12. DOI: 10.1002/jcp.21572. View

18.

Farre J, Roura S, Prat-Vidal C, Soler-Botija C, Llach A, Molina C . FGF-4 increases in vitro expansion rate of human adult bone marrow-derived mesenchymal stem cells. Growth Factors. 2007; 25(2):71-6. DOI: 10.1080/08977190701345200. View

19.

Zavan B, Giorgi C, Bagnara G, Vindigni V, Abatangelo G, Cortivo R . Osteogenic and chondrogenic differentiation: comparison of human and rat bone marrow mesenchymal stem cells cultured into polymeric scaffolds. Eur J Histochem. 2007; 51 Suppl 1:1-8. View

20.

Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D . Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8(4):315-7. DOI: 10.1080/14653240600855905. View